Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

271 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Impact of ammonia levels on outcome in clinically stable outpatients with advanced chronic liver disease.
Balcar L, Krawanja J, Scheiner B, Paternostro R, Simbrunner B, Semmler G, Jachs M, Hartl L, Stättermayer AF, Schwabl P, Pinter M, Szekeres T, Trauner M, Reiberger T, Mandorfer M. Balcar L, et al. Among authors: mandorfer m. JHEP Rep. 2023 Jan 23;5(4):100682. doi: 10.1016/j.jhepr.2023.100682. eCollection 2023 Apr. JHEP Rep. 2023. PMID: 36873421 Free PMC article.
The impact of interleukin 28B rs12979860 single nucleotide polymorphism and liver fibrosis stage on response-guided therapy in HIV/HCV-coinfected patients.
Mandorfer M, Neukam K, Reiberger T, Payer BA, Rivero A, Puoti M, Boesecke C, Baumgarten A, Grzeszczuk A, Zangerle R, Meyer-Olson D, Rockstroh JK, Trauner M, Pineda JA, Peck-Radosavljevic M. Mandorfer M, et al. AIDS. 2013 Nov 13;27(17):2707-14. doi: 10.1097/01.aids.0000432460.44593.ef. AIDS. 2013. PMID: 23835502
Revisiting predictors of virologic response to PEGIFN + RBV therapy in HIV-/HCV-coinfected patients: the role of metabolic factors and elevated GGT levels.
Mandorfer M, Reiberger T, Payer BA, Breitenecker F, Aichelburg MC, Obermayer-Pietsch B, Rieger A, Puoti M, Zangerle R, Trauner M, Peck-Radosavljevic M. Mandorfer M, et al. J Viral Hepat. 2014 Jan;21(1):33-41. doi: 10.1111/jvh.12118. Epub 2013 Aug 1. J Viral Hepat. 2014. PMID: 24329855 Clinical Trial.
IFNL4 ss469415590 variant shows similar performance to rs12979860 as predictor of response to treatment against Hepatitis C Virus genotype 1 or 4 in Caucasians.
Real LM, Neukam K, Herrero R, Guardiola JM, Reiberger T, Rivero-Juarez A, Salazar J, Mandorfer M, Merino D, Soriano V, Rivero A, Macías J, Pineda JA, Caruz A. Real LM, et al. Among authors: mandorfer m. PLoS One. 2014 Apr 18;9(4):e95515. doi: 10.1371/journal.pone.0095515. eCollection 2014. PLoS One. 2014. PMID: 24748394 Free PMC article.
271 results